港股IPO招股书披露先例 · 46 家公司，46 项
该类事项指企业在往绩记录期间产能利用率出现大幅波动，或不同生产基地、产品线之间的利用率明显分化。招股书一般于概要、风险因素、业务及财务资料章节列示各基地或产线的利用率数据，并解释波动原因，如新产线投产尚处爬坡阶段、市场需求变化、设备检修或停产升级、产品组合调整等，同时说明通过扩充产能、动态调整订单承接及优化生产安排予以应对。
During the Track Record Period, the utilization rate of our in-house packaging facility was 18.9%, 69.4% and 95.3%, respectively.
Business · 第 126 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看Outsourced packaging remains the predominant approach, particularly for our flagship products, as our established production partners offer stable yields and extensive production experience.
Business · 第 126 页
The utilization rate of our manufacturing facilities in 2023, 2024 and 2025 was 74.2%, 68.1%, and 90.1%, respectively.
Financial Information · 第 201 页
Our capacity utilization rate decreased from 74.2% in 2023 to 68.1% in 2024, primarily reflecting the temporary capacity fluctuation during production line upgrades to support SiPh applications, including the establishment of CW laser production lines.
Business · 第 147 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看In addition, one of these production bases in is currently undergoing production expansion to accommodate additional production facilities in response to the growing demand.
Business · 第 146 页
The utilization rate of our production facilities in the nine months ended September 30, 2025 was lower than the utilization rate of the corresponding period in 2024, because we launched a new production facility in Hubei in June 2024, which was still in the production ramp up stage, adjustments in customers’ procurement schedules, and scheduled major maintenance of the production facilities at Inner Mongolia.
Business · 第 127 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看While our Hubei production facility has a designed production capacity of 25,000 tons per annum, production began only after June 2024.
Business · 第 127 页
For our frozen food storage services, the total storage capacity purchased by our customers was 149,269 tonnes, 145,550 tonnes, 203,183 tonnes, 204,835 tonnes and 193,258 tonnes, in 2022, 2023, 2024 and the six months ended June 30, 2024 and 2025, respectively, at our southern frozen food storage base and northern frozen food storage base, representing a total storage capacity utilization rate of 96.7%, 94.3%, 88.1%, 94.8% and 83.8% in the same periods, respectively.
Financial Information · 第 175 页
We have experienced decreased storage capacity utilization rates at our northern frozen food storage base from July to September 2025, as compared to the six months ended June 30, 2025, primarily because certain of our customers exited storage spaces following the cessation of their own businesses which had been underperforming.
Summary · 第 15 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看The Phase V Expansion Project will strengthen our capabilities to serve the demand from existing and potential customers, capture greater market share, diversify our business opportunities and drive our revenue growth.
Financial Information · 第 175 页
For the years ended December 31, 2023 and 2024 and the six months ended June 30, 2025, we produced oligonucleotide drug substance of 3.45 kg, 4.25 kg and 3.17 kg, respectively, representing annual utilization rates of 69.0%, 85.0% and 63.4%, respectively.
Business · 第 344 页
The fluctuation in annual utilization rates primarily reflects variations in the number and stage of pipeline programs under development in each year/period during the Track Record Period, which result in different production batch requirements and quantities of drug substance needed.
Business · 第 344 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看Based on the purchase orders we have secured, we had an utilization rate of 35.0% in the Tianjin facility for the six months ended June 30, 2025.
Business · 第 344 页
The ore processing volume decreased significantly from 374.2 kt in 2023 to 321.8 kt in 2024, which was primarily due to production line upgrades and weather-induced delays.
Business · 第 179 页
Therefore, we adjusted and allocated our processing capacity to the existing ore inventory together with mineralised waste in 2022 and thus consequentially led to a reduction in our actual ore mining volume in the year.
Business · 第 180 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看By contrast, the combined impact of all the aforesaid factors was minimal in 2023, and accordingly, we succeeded in reaching an actual ore mining volume of approximately 400.0 kt in 2023.
Business · 第 180 页
Our revenue for capacitor base films decreased by 21.3% from RMB300.6 million in 2022 to RMB236.5 million in 2023, to a large extent due to a decrease in the production volume of capacitor base films mainly caused by a decrease in the production capacity in 2023 as compared to 2022.
Financial Information · 第 242 页
With the addition of new production lines, we expect our annual production capacity of capacitor base films to increase by 16,000 tons by 2027, representing a 134.4% increase from the annualized production capacity of 11,904 tons in 2024.
Business · 第 184 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看As a result, the delivery time of the manufacturing equipment for our production lines is approximately eight months, which is significantly lower than the industry average of three to five years.
Financial Information · 第 243 页
We reallocated the majority of our production capacity to 50ml injection specifications in 2022, resulting in more vials designed to be produced.
Business · 第 442 页
We meticulously monitor our production capacity in real-time and dynamically make adjustments based on current conditions and future projections.
Business · 第 443 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看To further support the clinical trials and future commercialization of our innovative drugs, we are rigorously assessing the expansion of our Baili-Bio Base.
Business · 第 439 页
During the Track Record Period, our in-house facility in Shanghai, reached an actual production volume of 4.4 million units, 1.5 million units, 2.2 million units, and 1.2 million units, with a design production capacity of 4.9 million, 1.7 million, and 2.6 million units, and 1.4 million units, at a utilization rate or 88.7%, 91.0%, 83.9%, and 85.5%, respectively.
Business · 第 235 页
The decrease in designed production capacity at our in-house facility in Shanghai reflects our strategic shift aligned with our long-term international growth objectives, and our plans to relocate our production capacity to Shanghai No. 2.
Business · 第 235 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看Subsequent to the Track Record Period, our in-house Shanghai No. 2 facility, with a total GFA of 100,000 sq.m., located in Jiashan commenced production in July 2025.
Summary · 第 22 页
In 2022, our utilization rate soared to an extraordinary 128.2% due to an unprecedented surge in demand for our smart home EV chargers.
Business · 第 271 页
The further decline in utilization rate from 2023 to 2024 was mainly due to the upgrading of manufacturing facilities to accommodate the production requirements of newer project models, while also influenced by the demand fluctuation from our customers.
Business · 第 271 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看In addition, the current low utilization rate of our Thai factory is due to its initial stage of production.
Business · 第 271 页
The utilization rate of the facility in Singapore for GASTROClear™ increased significantly from 34.8% in 2023 to 86.6% in 2024 mainly driven by the increase of the actual testing volume of GASTROClear™ of 12,287 in 2024 as compared to 4,989 tests in 2023, attributable to an increase in the sales of GASTROClear™.
During the Track Record Period, our allocated production capacity and actual production volume for GASTROClear™ fluctuated because of the adjustment based on (i) our expectation of the corresponding market demand, and (ii) our production strategy shift from a build-to-stock model to a build-to-order model.
Business · 第 399 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看For the same reason, the actual production volume decreased to 23,400 tests in 2024, and our utilization rate therefore decreased to 29.0% in 2024.
Business · 第 400 页
Capacity utilization rate (%) | 83.4 | 70.5 | 76.3
Business · 第 196 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看Currently, the majority of our production capacity is enabled domestically, while our overseas production capacity remains relatively small and is still in the ramp-up phase of mass production.
For 2022, 2023 and 2024, the utilization rates of our manufacturing facilities were 94.8%, 96.2% and 81.6%, respectively.
Financial Information · 第 370 页
Our Chuzhou Plant and Huai'an Plant recorded lower utilization rates in 2024 primarily because we proactively adjusted the production volume to strategically prioritize orders with higher profitability to improve our margin.
Business · 第 247 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看It subsequently decreased to 66.0% in the first quarter of 2025, as we deemed it financially prudent to not book overtime shifts in January and February 2025 in view of the average selling price of PV cells, and as such the holiday season and cold weather's effects on our production volume became more pronounced and consequently reduced our utilization rate, though after holiday season, it increased to 78.8% in March 2025 given the increase in the average selling price.
Business · 第 298 页
This fluctuation of the capacity utilization rate of our Zaozhuang plant during the Track Record Period was due to adjustments in our manufacturing plans based on anticipated market demand and our inventory levels.
Business · 第 225 页
The capacity utilization rate of our Yuyao plant in December 31, 2024 exceeded 100% as we optimized the shift arrangements of manufacturing staff during this year to meet production targets and fulfill the market demand for our dump trucks, resulting in the production output exceeding the designed capacity.
Business · 第 226 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看In anticipation of increasing demand for battery-electric loaders in the next five years, we constructed our second loader manufacturing plant in Wuhan, Hubei, which commenced operations in August 2024, with an annual design capacity of 5,000 units of loaders.
Business · 第 225 页
Therefore, we generally reach peak utilization rate of the production capacity in the fourth quarter of the year for such core components.
Business · 第 350 页
However, in 2023, we reached peak utilization of our production capacity of MEAs in the second quarter of the year because we launched the second production line of MEAs in Shanghai Plant in July 2023, which expansion doubled our production capacity for the third and fourth quarters, and in turn lowered the utilization rates such periods, notwithstanding that the production volumes in the third and fourth quarters were actually higher than the production volume in the second quarter.
Business · 第 350 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看In addition, we expect to further expand our production capability, which would enable us to ensure product availability, achieve economies of scale, enhance production efficiency and reduce average production cost to alleviate the effects of seasonality.
Business · 第 348 页
The lower utilization rate for the six months ended June 30, 2024 primarily resulted from slower sales as our sales volume decreased by approximately 10.4% compared to the six months ended June 30, 2023.
Business · 第 300 页
For the three months ended September 30, 2024, our utilization rate was 90.8%.
Business · 第 300 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看The actual volume of gold purified decreased from 13,702 kg in 2021 to 7,577 kg in 2022, and then to 6,270 kg in 2023.
Business · 第 300 页
The current capacity of our manufacturing facility enables us to produce 500,000 vials of Utidelone Injection per year.
Business · 第 347 页
Our utilization rate of the current production line was 5.5% for the year ended December 31, 2022, which reflected the decrease in the sales volume of Utidelone Injection resulting from the COVID-19 pandemic in 2022.
Business · 第 349 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看Considering the projected sales and the current inventory level, we adjusted our production plan and no vials of Utidelone Injection were produced for the five months ended May 31, 2024.
Business · 第 349 页
The utilization rate declined in 2022, primarily due to the COVID-19 outbreaks and the restrictions imposed in response at the time that affected the supply chain and the market demand for home appliances, which in turn affected our manufacturing volume.
Business · 第 220 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看The utilization rate increased in 2023 and the four months ended 30 April 2024, mainly due to increased consumer demand for our products, driven by enhanced product
Business · 第 220 页
For the year ended 31 December 2023, the utilisation rates of our two self-owned production facilities were approximately 100.9% and 70.1%, respectively.
Summary · 第 2 页
The utilisation rates of each of our selfowned production facilities was approximately 51.7% and 82.1% for the year ended 31 December 2022, and approximately 70.1% and 100.9% for the year ended 31 December 2023, respectively.
Business · 第 166 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看Our Directors managed to reduce idle capacity of us during the Track Record Period by establishing relationships with others customers.
Business · 第 166 页
Due to the lower average yearly temperature, the cultivation conditions of our Dalian Facility are slightly inferior as compared to other facilities, resulting in a relatively lower utilisation rate during the Track Record Period.
Business · 第 216 页
The lower utilisation rate of our cultivation facilities in FY2022 was primarily due to the resurgence of COVID-19 cases which affected our business operations.
Business · 第 216 页
公司的解释、律师意见及原文页码定位：在 Matters 中查看In addition, for the 9M2023, the utilisation rate of our Laixi Facility, Xi’an Facility and Dalian Facility was approximately 91.3%, 68.8% and 58.5%, respectively, while the overall utilisation rate of our three cultivation facilities is approximately 88.1%, which has returned to the FY2020 and FY2021 level.
Summary · 第 19 页